Adiponectin C1q/Tumor Necrosis Factor-Related Protein 13 (CTRP13) Protects against Renal Inflammation and Fibrosis in

Yongxia Li1,2, Wenzhe Wang2, Changxuan Liu2

  • 1Department of Rheumatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Biomedicines
|January 23, 2024
PubMed

Insights

C1q/tumor necrosis factor-related protein 13 (CTRP13) combats renal inflammation and fibrosis in obstructive nephropathy by inhibiting key signaling pathways. This discovery offers new therapeutic avenues for chronic kidney disease (CKD).

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Obstructive nephropathy involves renal inflammation and fibrosis, but mechanisms remain unclear.
  • C1q/tumor necrosis factor-related protein 13 (CTRP13) role in kidney disease is under investigation.
  • Reduced CTRP13 levels are observed in renal fibrosis patients and models.

Purpose of the Study:

  • Investigate CTRP13's effects on renal inflammation and fibrosis in obstructive nephropathy.
  • Elucidate the underlying molecular mechanisms of CTRP13's action.
  • Assess CTRP13 as a potential therapeutic target for chronic kidney disease (CKD).

Main Methods:

  • Established a mouse unilateral ureteral obstruction (UUO) model for renal dysfunction.
  • Utilized hematoxylin-eosin staining, immunofluorescence, Western blotting, and RT-qPCR.
  • Administered recombinant CTRP13 to assess its therapeutic potential.

Main Results:

  • CTRP13 expression was decreased in renal fibrosis patients and UUO mice.
  • CTRP13 administration reversed UUO-induced renal dysfunction, fibrosis, and tubular injury.
  • CTRP13 inhibited extracellular matrix proteins and pro-inflammatory mediators.
  • CTRP13's protective effects were linked to inactivating TGF-β/Smad and NF-κB p65 pathways.

Conclusions:

  • CTRP13 plays a crucial role in mitigating renal inflammation and fibrosis.
  • CTRP13 demonstrates therapeutic potential for obstructive nephropathy and CKD.
  • Inactivation of TGF-β/Smad and NF-κB pathways mediates CTRP13's protective effects.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
631
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645